Terms: = Prostate cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Diagnosis
36 results:
1. 5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder cancer: United States insurance claims data.
Del Giudice F; Belladelli F; Glover F; Basran S; Li S; Mulloy E; Pradere B; Soria F; Krajewski W; Nair R; Muncey W; Seranio N; Eisenberg ML
World J Urol; 2023 Oct; 41(10):2783-2791. PubMed ID: 37548746
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
3. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
[TBL] [Abstract] [Full Text] [Related]
4. Association between prior cancer diagnosis and osteoporosis: a matched case-control study.
Yang S; Wang N; Wang J; Lix LM; Leslie WD; Yuan B
Arch Osteoporos; 2022 Aug; 17(1):112. PubMed ID: 35960383
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With cancer in the United States.
Hawley JE; Sun T; Chism DD; Duma N; Fu JC; Gatson NTN; Mishra S; Nguyen RH; Reid SA; Serrano OK; Singh SRK; Venepalli NK; Bakouny Z; Bashir B; Bilen MA; Caimi PF; Choueiri TK; Dawsey SJ; Fecher LA; Flora DB; Friese CR; Glover MJ; Gonzalez CJ; Goyal S; Halfdanarson TR; Hershman DL; Khan H; Labaki C; Lewis MA; McKay RR; Messing I; Pennell NA; Puc M; Ravindranathan D; Rhodes TD; Rivera AV; Roller J; Schwartz GK; Shah SA; Shaya JA; Streckfuss M; Thompson MA; Wulff-Burchfield EM; Xie Z; Yu PP; Warner JL; Shah DP; French B; Hwang C;
JAMA Netw Open; 2022 Jan; 5(1):e2142046. PubMed ID: 34982158
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic prostate cancer Based on Immunohistochemistry, Data Mining, and
Sun Y; Chen G; He J; Li JX; Gan XY; Ji SF; Huang Y; Chen XH; He ML; Huang ZG
Cancer Biother Radiopharm; 2022 Aug; 37(6):466-479. PubMed ID: 34582697
[No Abstract] [Full Text] [Related]
7. Diagnostic performance of deep learning models for detecting bone metastasis on whole-body bone scan in prostate cancer.
Han S; Oh JS; Lee JJ
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):585-595. PubMed ID: 34363089
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of Modifiable Factors for the Association of Marital Status With cancer-Specific Survival.
Chen ZH; Yang KB; Zhang YZ; Wu CF; Wen DW; Lv JW; Zhu GL; Du XJ; Chen L; Zhou GQ; Liu Q; Sun Y; Ma J; Xu C; Lin L
JAMA Netw Open; 2021 May; 4(5):e2111813. PubMed ID: 34047792
[TBL] [Abstract] [Full Text] [Related]
9. Development and head-to-head comparison of machine-learning models to identify patients requiring prostate biopsy.
Yu S; Tao J; Dong B; Fan Y; Du H; Deng H; Cui J; Hong G; Zhang X
BMC Urol; 2021 May; 21(1):80. PubMed ID: 33993876
[TBL] [Abstract] [Full Text] [Related]
10. Can dynamic contrast enhanced MRI predict gleason score in prostate cancer? a systematic review and meta analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2021 Nov; 39(11):784.e17-784.e25. PubMed ID: 33934966
[TBL] [Abstract] [Full Text] [Related]
11. Performance of Three Inherited Risk Measures for Predicting prostate cancer Incidence and Mortality: A Population-based Prospective Analysis.
Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
[TBL] [Abstract] [Full Text] [Related]
12. BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.
Wang X; Wang C; Yan G; Kang Y; Sun G; Wang S; Zou R; Sun H; Zeng K; Song H; Liu W; Sun N; Liu W; Zhao Y
EBioMedicine; 2020 Mar; 53():102685. PubMed ID: 32113162
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in prostate cancer.
Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
[TBL] [Abstract] [Full Text] [Related]
14. prostate cancer Incidence and Mortality in Relationship to Family History of prostate cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract] [Full Text] [Related]
15. Cost-Effectiveness of Active Surveillance, Radical prostatectomy and External Beam Radiotherapy for Localized prostate cancer: An Analysis of the ProtecT Trial.
Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
[TBL] [Abstract] [Full Text] [Related]
16. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract] [Full Text] [Related]
17. A Deep Learning-Based Approach for the Detection and Localization of prostate cancer in T2 Magnetic Resonance Images.
Alkadi R; Taher F; El-Baz A; Werghi N
J Digit Imaging; 2019 Oct; 32(5):793-807. PubMed ID: 30506124
[TBL] [Abstract] [Full Text] [Related]
18. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of prostate cancer.
Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
[TBL] [Abstract] [Full Text] [Related]
19. prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket.
Brassetti A; Lombardo R; Emiliozzi P; Cardi A; Antonio V; Antonio I; Aldo S; Tommaso R; Alberto P; Gianluca D
Urology; 2018 Jan; 111():129-135. PubMed ID: 29032238
[TBL] [Abstract] [Full Text] [Related]
20. Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Gurioli G; Salvi S; Martignano F; Foca F; Gunelli R; Costantini M; Cicchetti G; De Giorgi U; Sbarba PD; Calistri D; Casadio V
J Transl Med; 2016 Aug; 14(1):249. PubMed ID: 27576364
[TBL] [Abstract] [Full Text] [Related]
[Next]
